Paolo A. Ascierto (@pascierto) 's Twitter Profile
Paolo A. Ascierto

@pascierto

Ricercatore Oncologo presso Istituto Nazionale Tumori Fondazione Pascale di Napoli.
Medical oncologist from National Cancer Institute of Naples, Italy

ID: 523724994

calendar_today13-03-2012 22:03:43

1,1K Tweet

1,1K Followers

252 Following

Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

Prevention takes the stage at #Sanremo! Together with Minister Orazio Schillaci, Iโ€™ll be launching #LaPrevenzioneInDieciNote, a campaign on cancer prevention. Watch the live stream on YouTube starting at 10 AM: youtube.com/watch?v=1-RlHrโ€ฆ #Prevention #Sanremo2025

Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

At #Sanremo2025, we talked about health, research & early diagnosis with Minister #OrazioSchillaci and amazing guests. Discover the 10 key notes for prevention: youtube.com/watch?v=MdRwKGโ€ฆ #LaPrevenzioneInDieciNote #Prevention #Care

At #Sanremo2025, we talked about health, research & early diagnosis with Minister #OrazioSchillaci and amazing guests.
Discover the 10 key notes for prevention: youtube.com/watch?v=MdRwKGโ€ฆ

#LaPrevenzioneInDieciNote #Prevention #Care
Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

SCITO 2025, the work continues! Great discussions on the present & future of cancer immunotherapy, sharing insights with top experts. Research never stops: science & clinical practice must move forward together. See you next year! #SCITO #Immunotherapy #Oncology

SCITO 2025, the work continues!
Great discussions on the present & future of cancer immunotherapy, sharing insights with top experts. Research never stops: science & clinical practice must move forward together.
See you next year!
#SCITO #Immunotherapy #Oncology
Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

New #JITC article: Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020 bit.ly/43lQM8O Paolo A. Ascierto

New #JITC article: Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020 
bit.ly/43lQM8O <a href="/PAscierto/">Paolo A. Ascierto</a>
Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

Science & innovation meet in Cancรบn for the Dual Block launch by Bristol Myers Squibb! Tomorrow, we take another step in the immunotherapy revolution. Letโ€™s shape the future together! #DualBlock #AgentesiO #BMSSummit #Innovation

Science &amp; innovation meet in Cancรบn for the Dual Block launch by Bristol Myers Squibb! Tomorrow, we take another step in the immunotherapy revolution. Letโ€™s shape the future together!
#DualBlock #AgentesiO #BMSSummit #Innovation
Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

Last weekend in Cancรบn, we completed a top mission: the Dual Block launch by Bristol Myers Squibb for Mexico! Science, innovation, and the drive to push oncology immunotherapy even further. The next mission? Weโ€™re always ready. #DualBlock #AgentesiO #Innovation

Last weekend in Cancรบn, we completed a top mission: the Dual Block launch by Bristol Myers Squibb for Mexico! Science, innovation, and the drive to push oncology immunotherapy even further. The next mission? Weโ€™re always ready.
#DualBlock #AgentesiO #Innovation
Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

The mRNA cancer vaccine works, and we aim to make it available within two years. A future where this therapy becomes a reality is closer than ever. Read my interview with Secolo d'Italia here: secoloditalia.it/2025/03/loncolโ€ฆ #CancerResearch #Oncology #Innovation

Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

The MELODY-1 study is exploring how 9 gut bacteria could enhance immunotherapy for advanced melanoma. Research is the key to the future of oncology! Discussed at #SCITO. Read more on Il Sole 24 Ore: ilsole24ore.com/art/melanoma-aโ€ฆ

Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

๐…๐ž๐ฌ๐ญ๐ข๐ฏ๐š๐ฅ ๐๐ž๐ฅ๐ฅ๐š ๐๐ซ๐ž๐ฏ๐ž๐ง๐ณ๐ข๐จ๐ง๐ž was a great opportunity to promote a culture of health! An integrated approach to prevention means protecting our future. Thanks to #LILT & all speakers for the insightful discussion! #PreventionFirst #HealthMatters

๐…๐ž๐ฌ๐ญ๐ข๐ฏ๐š๐ฅ ๐๐ž๐ฅ๐ฅ๐š ๐๐ซ๐ž๐ฏ๐ž๐ง๐ณ๐ข๐จ๐ง๐ž was a great opportunity to promote a culture of health! An integrated approach to prevention means protecting our future.
Thanks to #LILT &amp; all speakers for the insightful discussion!
#PreventionFirst #HealthMatters
Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

Immunotherapy has revolutionized melanoma treatment. In my interview with #INNLIFES, I discuss its evolution, the role of the microbiota, and future challenges in the fight against this cancer. Research never stops! Read the interview ๐Ÿ‘‰ innlifes.com/biotech/paolo-โ€ฆ #Immunotherapy

Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

Honored to speak at the 11th World Congress of Melanoma, a crucial opportunity to share best practices and strengthen global collaboration in melanoma care. Thanks to #EADO, #MelanomaWorldSociety, and all colleagues driving progress! #Melanoma #EADO2025 #WorldMelanomaCongress

Honored to speak at the 11th World Congress of Melanoma, a crucial opportunity to share best practices and strengthen global collaboration in melanoma care.
Thanks to #EADO, #MelanomaWorldSociety, and all colleagues driving progress!
#Melanoma #EADO2025 #WorldMelanomaCongress
Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

Great discussion at the 11th World Congress of Melanoma during the symposium "Evolving TCR therapy in melanoma". I shared insights on TCR-based therapies in metastatic uveal melanoma. Thanks to all colleagues for the enriching exchange! #Melanoma #EADO2025 #Immunotherapy

Great discussion at the 11th World Congress of Melanoma during the symposium "Evolving TCR therapy in melanoma".
I shared insights on TCR-based therapies in metastatic uveal melanoma.
Thanks to all colleagues for the enriching exchange!
#Melanoma #EADO2025 #Immunotherapy
Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

Art and science united against melanoma. With Roberto Vecchioni, weโ€™re turning music into a message of prevention. See you in Naples, April 15 ๐ŸŽญ ๐Ÿ‘‰ napolitoday.it/benessere/saluโ€ฆ #Melanoma #Health #Prevention

Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

๐ŸŽค "Itโ€™s a beautiful thing, and Iโ€™m truly happy to do it." Prof. Roberto Vecchioni brings his "Tra il silenzio e il tuono Tour" to Naples โ€” a special date dedicated to cancer prevention. ๐Ÿ“ Teatro Augusteo | ๐Ÿ—“๏ธ April 15, 2025 #Health #Prevention #FondazioneMelanoma

Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

Last night in Naples: a sold-out Teatro Augusteo for Roberto Vecchioniโ€™s concert dedicated to cancer prevention. An unforgettable evening of music, memory, and meaning. Thank you, Maestro. ๐Ÿ’œ #MelanomaAwareness #TraIlSilenzioEIlTuono #FondazioneMelanoma crcnews.it/roberto-vecchiโ€ฆ

Last night in Naples: a sold-out Teatro Augusteo for <a href="/RVecchioni/">Roberto Vecchioni</a>โ€™s concert dedicated to cancer prevention.
An unforgettable evening of music, memory, and meaning.
Thank you, Maestro. ๐Ÿ’œ
#MelanomaAwareness #TraIlSilenzioEIlTuono #FondazioneMelanoma

crcnews.it/roberto-vecchiโ€ฆ
Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

With summer approaching, don't forget: *basal cell carcinoma* is the most common skin cancerโ€”often caused by unprotected sun exposure. Protect your skin. Respect the sun. #SkinCancerPrevention #OncoDermatology repubblica.it/salute/dossierโ€ฆ

Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

Introducing #SoloCoseBelle โ€” a space to celebrate the small and meaningful moments that make life beautiful. Inspired by a personal story and the bond with #FrancoDiMare. This is just the beginning. ๐Ÿ‘‰ solocosebelle.eu/solocosebelle-โ€ฆ

Paolo A. Ascierto (@pascierto) 's Twitter Profile Photo

May is Melanoma Awareness Month. Read the 7 common mistakes that put your skin at riskโ€”and how to avoid them: ๐Ÿ‘‰ corriere.it/salute/sportelโ€ฆ #Melanoma #Prevention #SkinHealth #FondazioneMelanoma

Oncoinfo (@oncoinfo_it) 's Twitter Profile Photo

#ASCO25 | Un insight di Paolo A. Ascierto sullo studio C-POST: cemiplimab in adiuvante nel paziente con #CSCC ad alto rischio. Non perdere il commento completo tra poco sul Day2 di OncoInfo! ๐Ÿ”œ Istituto Nazionale Tumori Pascale